naphthalenediimide has been researched along with Carcinoma, Neuroendocrine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beretta, GL; Borrello, MG; Doria, F; Folini, M; Freccero, M; Lanzi, C; Lopergolo, A; Perrone, R; Richter, SN; Tortoreto, M; Zaffaroni, N; Zuco, V | 1 |
1 other study(ies) available for naphthalenediimide and Carcinoma, Neuroendocrine
| Article | Year |
|---|---|
Targeting of RET oncogene by naphthalene diimide-mediated gene promoter G-quadruplex stabilization exerts anti-tumor activity in oncogene-addicted human medullary thyroid cancer.
Topics: Animals; Antineoplastic Agents; Carcinoma, Neuroendocrine; Cell Line, Tumor; Down-Regulation; Female; G-Quadruplexes; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Imides; Ligands; Mice; Mice, SCID; Mutation; Naphthalenes; Neoplasm Transplantation; Promoter Regions, Genetic; Proto-Oncogene Mas; Proto-Oncogene Proteins c-ret; Thyroid Neoplasms | 2016 |